Platelet-Rich Plasma (PRP) for Hair Loss

Platelet-rich plasma (PRP) is an in-office procedure in which a patient's own blood is drawn, processed to concentrate the platelets, and injected into the scalp. It has been used in orthopedics, dentistry, and dermatology for over a decade, with hair loss becoming one of the more researched applications in the last five years. The published evidence supports a real, measurable benefit in androgenetic alopecia, particularly as an adjunct to prescription treatment. This page covers the mechanism, the evidence, the protocols, and the trade-offs.

What PRP is and how it is prepared

The process involves drawing a small volume of the patient's blood (typically 15 to 60 mL), centrifuging it to separate components by density, and isolating the layer that is rich in platelets and plasma but depleted of red blood cells. The resulting fluid contains a concentration of platelets typically four to seven times higher than baseline blood.

Platelets contain a variety of growth factors stored in their alpha granules: platelet-derived growth factor (PDGF), vascular endothelial growth factor (VEGF), epidermal growth factor (EGF), insulin-like growth factor (IGF-1), and transforming growth factor beta (TGF-β), among others. When the activated platelets are injected into the scalp, these growth factors are released locally and are thought to stimulate follicle activity, prolong the anagen phase, and improve perifollicular vascularization.

PRP preparation protocols vary across clinics. Some use single-spin centrifugation; others use double-spin. Some activate the platelets with calcium chloride or thrombin before injection; others rely on tissue contact for activation. The variation in protocols complicates interpreting trials, but the general approach is similar.

The mechanism for hair-loss benefit

The proposed mechanism is multifactorial:

• Direct stimulation of dermal papilla cells. Several in vitro studies show that PRP increases proliferation and survival of the dermal papilla cells that drive follicle activity.
• Anagen extension. PRP appears to lengthen the anagen phase, similar to the effect of minoxidil but through different upstream signaling.
• Improved vascularization. Increased VEGF activity locally may improve blood supply to follicles.
• Anti-inflammatory effects. PRP modulates inflammatory cytokines, which may reduce chronic low-grade scalp inflammation that contributes to follicle stress.

The combined effect, in theory, is to shift follicles toward growth and to improve the quality of hair they produce. The clinical data is consistent with these mechanisms.

What the evidence shows

Multiple randomized controlled trials and meta-analyses have examined PRP for androgenetic alopecia. The consistent findings:

• PRP produces measurable improvements in hair density and shaft caliber over three to six months, with statistical significance over saline controls in most trials.
• The effect is larger when PRP is combined with topical minoxidil than with either monotherapy.
• Early-to-moderate pattern loss responds better than advanced loss, presumably because more follicles are still capable of cycling.
• Women with female-pattern hair loss show similar response patterns to men.

The magnitude of effect varies across trials but is typically in the range of 20 to 40 percent improvement in hair density over baseline, smaller than prescription combination therapy but meaningful as an adjunct.

A few cautionary notes:

• Protocols are not standardized. Different centrifugation methods, different activation approaches, and different injection volumes produce different effective doses of growth factors. Comparing trials directly is harder than for standardized prescription medications.
• The placebo effect for any in-office procedure with social proof and significant patient expectation is non-trivial. Trial design matters.
• Long-term durability of effect is less well-characterized. Most trials report on six to twelve months of follow-up; ten-year data is largely absent.

Typical protocols and what a session involves

The standard PRP protocol for hair loss involves an initial series followed by maintenance:

Induction phase: three sessions, spaced four to six weeks apart. Each session takes roughly 60 to 90 minutes and includes the blood draw, centrifugation, and a series of injections across the affected scalp areas.

Maintenance phase: one session every three to six months, depending on response and clinical judgment.

The injection itself uses fine-gauge needles (typically 30-gauge) to deliver small volumes of PRP across the affected scalp. The number of injection points varies, but a typical session involves 30 to 60 small injections covering the scalp areas where treatment is targeted.

Discomfort varies. Many clinics use topical anesthetic creams applied to the scalp 20 to 30 minutes before injection. Some patients also receive a small nerve block. Most patients describe the procedure as uncomfortable but tolerable.

Recovery is minimal. The scalp is usually pink and tender for the first 24 hours and may show small areas of bruising or pinpoint bleeding at injection sites. Patients are generally instructed to avoid washing the scalp for 24 to 48 hours and to avoid strenuous exercise that day.

Cost and access

PRP for hair loss is generally not covered by insurance, since androgenetic alopecia is classified as cosmetic in most insurance frameworks. Typical out-of-pocket costs are:

• Individual session: $500 to $1,500 depending on geography, clinic type, and PRP protocol
• Induction series (three sessions): $1,500 to $4,500
• Maintenance: $500 to $1,500 per session, two to four times per year ongoing

Total first-year cost is typically $2,500 to $6,000. Ongoing maintenance is in the range of $1,000 to $4,000 per year. For most patients, this represents a substantial financial commitment.

The cost compared to prescription medication is notable. A year of generic finasteride and topical minoxidil typically costs $300 to $800 total. PRP delivers a smaller marginal benefit at five to ten times the cost. The framing that fits this trade-off is usually PRP as an adjunct for patients who want incremental improvement on top of prescription therapy and have the means and willingness to invest in it.

Where PRP fits

The reasonable use cases for PRP:

• As an adjunct to prescription therapy in patients who have plateaued or want to optimize results
• As a primary option for patients with strong preferences against pharmacologic treatment, with the caveat that the effect will be smaller than prescription therapy
• For patients planning a hair transplant, PRP injected at the time of surgery and in the post-operative period may improve graft survival (data is preliminary but reasonable)
• For specific subsets of female-pattern hair loss where prescription options are limited (pregnancy, breastfeeding, contraindications to spironolactone or oral minoxidil)

For most patients, the right framing is to start with prescription therapy (finasteride, minoxidil, or both), achieve whatever response that produces over 6 to 12 months, and then evaluate whether PRP is worth adding for incremental improvement.

Side effects and considerations

PRP has a strong safety profile because the injected material is autologous (the patient's own blood). Allergic reactions are essentially impossible, and disease transmission risk is minimal. The procedure-related side effects are:

• Mild scalp tenderness, bruising, or swelling for 24 to 48 hours
• Pinpoint bleeding at injection sites
• Rarely, infection at injection sites (low risk with sterile technique)
• Headache or scalp discomfort for the day after the procedure

PRP is not appropriate for patients with active scalp infections, certain blood disorders (severe thrombocytopenia, platelet dysfunction), or active cancer in the head and neck region.

Putting it together

PRP is one of the better-supported non-prescription approaches for androgenetic alopecia. The evidence base is real, the safety profile is strong, and the mechanism is biologically plausible. The trade-offs are cost, time commitment, and a modest absolute effect compared to prescription therapy. For most patients, the right framing is PRP as a meaningful adjunct rather than a primary treatment, layered on top of established prescription medication for those who want and can afford incremental improvement.

For a structured assessment of how PRP and other alternatives fit a specific situation, a medical evaluation is the most efficient starting point. Curekey's hair assessment is one way to start, and the broader alternatives cluster covers the wider context.

Key references

• Avci P et al. Lasers Surg Med, 2014. Low-level laser (light) therapy (LLLT) for treatment of hair loss.
• Dhurat R et al. Int J Trichology, 2013. A randomized evaluator-blinded study of effect of microneedling in androgenetic alopecia.
• Pierard-Franchimont C et al. Dermatology, 1998. Ketoconazole shampoo: effect of long-term use in androgenic alopecia.